Cannabinoids are a group of compounds found in the marijuana plant (cannabis sativa). They are said to have anti inflammatory properties because of their ability to bind to cannabinoid receptors in the body. Cannabinoid receptors are located in the endocannabinoid system and this acts as a playground for homeostatic and physiological functions such as pain regulation in the central nervous system and peripheral tissues. Tetrahydrocannabinol (THC) is one of the constituents of cannabinoids and is said to give the user a psychotropic side effect when induced. Cannabinoid (CBD) is another constituent of cannabinoids and this appears to have a great potential in treating chronic pain as it is very safe to use. This paper will look at how the endocannabinoid system works with cannabinoids in order to be therapeutic to treat people who suffer from chronic pain arising from such diseases like multiple sclerosis.
Here is the full scientific article if you wish to download it.
Smoking Cannabis can be pose a threat to chronic pain patients
Cannabis research shows that CBD’s can be efficient in treating different types of chronic pain and also has the potential to treat central neuropathic pain and inflammation. However, if CBD’s are smoked in the form of cannabis, the psychotropic effects of THC may be adverse and cause long-term cognitive misbehaviour. Also, smoking is bad for your lungs and this could actually worsen the existing chronic pain.
CBD’s may treat chronic pain
There needs to be more clinical trials into the acute dosing of medical marijuana in patients with chronic pain. This is a major barrier in the industry, however once this is surpassed and the therapeutic potential of CBD’s are realised, then they can be used as the novel drug to treat chronic pain. CBD’s potential lies with their bioavailability, easiness to administrer, non pyschotave properties and that they can provide millions of humans with chronic pain a safe an effective pain relief.